MariMed Inc.
MRMD
$0.11
-$0.02-15.39%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 39.61M | 37.96M | 39.00M | 40.59M | 40.44M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 39.61M | 37.96M | 39.00M | 40.59M | 40.44M |
| Cost of Revenue | 23.58M | 22.82M | 26.29M | 23.81M | 23.53M |
| Gross Profit | 16.03M | 15.14M | 12.71M | 16.78M | 16.91M |
| SG&A Expenses | 14.75M | 15.88M | 13.97M | 15.07M | 15.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 38.33M | 38.69M | 40.26M | 38.88M | 39.13M |
| Operating Income | 1.28M | -739.00K | -1.26M | 1.71M | 1.31M |
| Income Before Tax | -579.00K | -2.59M | -3.25M | -340.00K | -773.00K |
| Income Tax Expenses | 691.00K | 2.83M | 4.95M | 655.00K | 866.00K |
| Earnings from Continuing Operations | -1.27M | -5.42M | -8.20M | -995.00K | -1.64M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.00K | -32.00K | -3.00K | -16.00K | -12.00K |
| Net Income | -1.27M | -5.45M | -8.20M | -1.01M | -1.65M |
| EBIT | 1.28M | -739.00K | -1.26M | 1.71M | 1.31M |
| EBITDA | 4.36M | 2.02M | 1.79M | 4.40M | 4.12M |
| EPS Basic | 0.00 | -0.01 | -0.02 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.01 | -0.02 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 389.90M | 382.56M | 381.25M | 380.60M | 379.51M |
| Average Diluted Shares Outstanding | 389.90M | 382.56M | 381.25M | 380.60M | 379.51M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -11.87% | -- |